Stories from The University of Texas Health Science Center at Houston (UTHealth Houston)
September 7, 2022
A newly developed agonistic antibody reduced the amyloid pathology in mice with Alzheimer’s disease, signaling its promise as a potential treatment for the disease, according to a team of researchers at UTHealth Houston.
September 2, 2022
Katherine Loveland, PhD, with McGovern Medical School at UTHealth Houston, received a grant from the Health Resources and Services Administration to train psychology interns in substance use disorder (SUD) and opioid use disorder (OUD) trauma, and telehealth with underserved communities.
September 1, 2022
By comparing the risk of the first aortic surgical or medical event for patients with the gene mutation they carry, researchers with UTHealth Houston were able to tell which of seven common genes associated with thoracic aortic disease were more likely to lead to earlier, aggressive disease and death.
September 1, 2022
A clinical trial investigating the effects of different treatments, including light exercise and screen time restrictions, on recovery from a sport-related concussion among adolescents has opened for enrollment at UTHealth Houston.
August 31, 2022
The rate of underrepresented in medicine (URiM) women in the pediatric field have significantly increased, but the rates have remained stagnant and decreased in Black men, according to researchers with UTHealth Houston.
August 30, 2022
Researchers at UTHealth Houston and Baylor College of Medicine, along with the Houston Fire Department (HFD), are launching a new clinical trial for a medication to treat trauma-related severe blood loss. The Houston site is participating with other trauma centers across the U.S. in this phase II trial.
August 30, 2022
Imagine having to drink a solution of cornstarch and water every four hours to survive, and that missing a dose, even by 15 minutes, could lead to seizures and death. This is the reality for Rebecca Tarrence, who has glycogen storage disease type 1a (GSDIa), a rare genetic disease caused by the presence of two genetic changes on the same gene affecting glucose production.
August 26, 2022
UTHealth Houston ranks No. 2 in Texas in the 2022 America’s Best Employers by State, according to Forbes.
August 25, 2022
Radha Korupolu, MD, associate professor in the Department of Physical Medicine and Rehabilitation with McGovern Medical School at UTHealth Houston, has received a 3-year, $714,096 grant from the National Center for Complementary & Integrative Health, a branch of the National Institutes of Health, for a pilot study on mindfulness mediation training.
August 24, 2022
Researchers are hoping to determine if taking a statin could help prevent dementia and other functional disabilities in older adults. The randomized, controlled study, Pragmatic Evaluation of Events and Benefits of Lipid-lowering in Older Adults (PREVENTABLE), is enrolling patients over the age of 75.
Use the form below to perform a new search.